Image

Healing At Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

Recruiting
18 years of age
Female
Phase N/A

Powered by AI

Overview

The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.

Description

Healing at Home (H@H) 2.0 is a comprehensive technology-based postpartum support program which provides 24/7 support to individuals through use of an SMS chatbot for six weeks postpartum. This will be a randomized controlled trial (RCT) with an intervention arm consisting of patients who are planning to be discharged at routine timing (as determined by their clinical team) with access to H@H 2.0 postpartum SMS chatbot platform and a control arm which consists of usual postpartum care.

Eligibility

Inclusion Criteria:

  • Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
  • Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
  • Able to speak, read and write English
  • Age ≥18
  • Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
  • Completion of clinically administered EPDS during inpatient stay
  • Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery

Exclusion Criteria:

  • Unable to provide informed consent
  • Baby not discharged with mother at postpartum discharge
  • Does not have access to a mobile phone

Study details

Depression, Postpartum, Postpartum Care

NCT06877104

University of Pennsylvania

4 April 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.